Merck KGaA / MilliporeSigma (CDMO) vs Pfizer CentreOne: CDMO Comparison

How does Merck KGaA / MilliporeSigma (CDMO) compare to Pfizer CentreOne?

As of Jul 2026, Merck KGaA / MilliporeSigma (CDMO): 2 FDA inspections (including 0 NAI, 2 VAI and 0 OAI), 2 EMA/MHRA GMP certificates. Signal Score 81.9. Pfizer CentreOne: 4 FDA inspections (including 3 NAI, 1 VAI and 0 OAI), 14 EMA/MHRA GMP certificates. Signal Score 90.1. Counts are the established FDA, EMA and MHRA records on each profile. CDMOs cannot pay to change a score.

Side-by-side comparison of Merck KGaA / MilliporeSigma (CDMO) and Pfizer CentreOne on independent FDA inspections, EMA and MHRA GMP certificates, clinical-program activity, and CDMO Signal Score. Data sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.

Darmstadt, DE · St. Louis, MO
Signal Score
82/100
Quality (FDA + GMP)
99/100
FDA inspections
2
— NAI / VAI / OAI
0 / 2 / 0
FDA warning letters
0
EMA GMP certificates (active)
2
MHRA GMP certificates (compliant)
0
Clinical programs (matched)
22
Capacity
—
Modalities
mRNA, Biologics, Cell Therapy
Kalamazoo, MI · McPherson, KS
Signal Score
90/100
Quality (FDA + GMP)
100/100
FDA inspections
4
— NAI / VAI / OAI
3 / 1 / 0
FDA warning letters
0
EMA GMP certificates (active)
14
MHRA GMP certificates (compliant)
0
Clinical programs (matched)
369
Capacity
—
Modalities
Biologics, mRNA, Small Molecule API, Oral Solid Dose, High-Potency APIs, Sterile Fill-Finish

Key differences

  • Both maintain clean enforcement records — no FDA OAI classifications or warning letters on file for either CDMO.
  • Pfizer CentreOne has materially broader EMA GMP coverage (14 active certificates vs 2) — stronger EU footprint.
  • Pfizer CentreOne appears as a manufacturing partner on more matched clinical programs (369 vs 22) — a broader sponsor book.

Across the cross-modality scorecard, Pfizer CentreOne carries the higher composite Signal Score — but the right choice depends on the specific modality, phase, and geography of the program.

Frequently asked: Merck KGaA / MilliporeSigma (CDMO) vs Pfizer CentreOne

How does Merck KGaA / MilliporeSigma (CDMO) compare to Pfizer CentreOne?

On CDMO Signal's composite Signal Score, Merck KGaA / MilliporeSigma (CDMO) is 82/100 and Pfizer CentreOne is 90/100; Merck KGaA / MilliporeSigma (CDMO) has 2 FDA inspections on record vs 4 for Pfizer CentreOne; European coverage is 2 active EMA+MHRA certificates for Merck KGaA / MilliporeSigma (CDMO) vs 14 for Pfizer CentreOne. Both are tracked in the CDMO Signal directory. The scorecard above breaks down every metric side by side — use it alongside each CDMO's individual profile for the full regulatory and clinical footprint.

Which has the stronger FDA inspection record, Merck KGaA / MilliporeSigma (CDMO) or Pfizer CentreOne?

Both Merck KGaA / MilliporeSigma (CDMO) and Pfizer CentreOne maintain clean enforcement records on file — no FDA warning letters and no OAI classifications. Merck KGaA / MilliporeSigma (CDMO) has 2 FDA inspections on record; Pfizer CentreOne has 4.

How do Merck KGaA / MilliporeSigma (CDMO) and Pfizer CentreOne compare on European GMP coverage?

Merck KGaA / MilliporeSigma (CDMO) holds 2 active EMA GMP certificates and 0 MHRA / UK certificates. Pfizer CentreOne holds 14 active EMA GMP certificates and 0 MHRA / UK certificates. Use these counts as a proxy for the breadth of each CDMO's European regulatory footprint.

Which is more active in clinical-stage manufacturing — Merck KGaA / MilliporeSigma (CDMO) or Pfizer CentreOne?

Merck KGaA / MilliporeSigma (CDMO) is matched to 22 ClinicalTrials.gov records as a manufacturing partner; Pfizer CentreOne is matched to 369. Higher counts indicate broader sponsor exposure but say nothing about approved-product track record — pair this number with each CDMO's profile page for context.

What does the Signal Score gap mean in practice?

Merck KGaA / MilliporeSigma (CDMO) carries a Signal Score of 82/100 and Pfizer CentreOne carries 90/100 — a small lead for Pfizer CentreOne. The Signal Score combines quality (FDA inspections + EMA/MHRA GMP), operational performance, financial stability, and capacity intelligence. CDMOs cannot pay to influence their score.

Evaluating Merck KGaA / MilliporeSigma (CDMO) and Pfizer CentreOne for a program?

Use the free AI matchmaker to weigh both against your specific requirements — capacity, modality, regulatory record, geography — and surface other qualified options.

Find & compare CDMOs →
Sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.